Friday, August 03, 2012 8:46:47 PM
...I sold out today...was sincerely hoping Ampha would be reversed making my 3 year $65 SP prognostication feasable.
For me instead today's judgement was strike three.
...As to your Bullish scenarios.
1/
Why didn't NVS takeout MNTA after M enox FDA approval?
Now we know why.
2/
Baxter got many MNTA compounds for didley squat $$$ up front....and confirmed yesterday...two more for free.
(another reason Bax won't be buying out MNTA)
402 will require years of trials.
3/
Today's judgement sets MNTA back until at least Jan/13 and I can only see mnta settling at horrible terms...so they may as well go to trial... they will wait to see if they are allowed to.
All in all, imo,
...MNTA mgmnt knew all along they were longshot winners in today's outcome
...and who knows what the copax scenarios will be like in 2014/2015
hence their deal with Baxter.
y3
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
